Jean Henri Bourhis

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 3

Top Topics

Acute Myeloid Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Chronic Kidney Disease

Tyrosine Kinase

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Christof Scheid, Diderik-Jan Eikema, Michel van Gelder, Urpu Salmenniemi, Johan Maertens, Jakob R Passweg, Didier Blaise, Jennifer L Byrne, Nicolaus M Kröger, Katja Sockel, Patrice Chevallier, Jean Henri Bourhis, Jan J Cornelissen, Henrik Sengeløv, Juergen Finke, John A Snowden, Tobias Gedde-Dahl, Jérôme Cornillon, Urs Schanz, Amit Patel, Linda Koster, Liesbeth C de Wreede, Patrick J Hayden, Kavita Raj, Joanna Drozd-Sokołowska, Carmelo Gurnari, Francesco Onida, Donal P McLornan, Marie Robin, Ibrahim Yakoub Agha
Does IPSS-R downstaging before transplantation improve the prognosis of patients with myelodysplastic neoplasms? Blood 144 (4) (2024)
Christof Scheid, Diderik-Jan Eikema, Michel van Gelder, Urpu Salmenniemi, Johan Maertens, Jakob R Passweg, Didier Blaise, Jennifer L Byrne, Nicolaus M Kröger, Katja Sockel, Patrice Chevallier, Jean Henri Bourhis, Jan J Cornelissen, Henrik Sengeløv, Juergen Finke, John A Snowden, Tobias Gedde-Dahl, Jérôme Cornillon, Urs Schanz, Amit Patel, Linda Koster, Liesbeth C de Wreede, Patrick J Hayden, Kavita Raj, Joanna Drozd-Sokołowska, Carmelo Gurnari, Francesco Onida, Donal P McLornan, Marie Robin, Ibrahim Yakoub Agha
Does IPSS-R downstaging before transplantation improve the prognosis of patients with myelodysplastic neoplasms? Blood 144 (4) (2024)
Ali Bazarbachi, Myriam Labopin, Tobias Gedde-Dahl, Peter Pal Remenyi, Edouard Forcade, Nicolaus M Kröger, Gerard Sociè, Charles F Craddock, Jean Henri Bourhis, Jurjen Versluis, Ibrahim Yakoub Agha, Urpu Salmenniemi, Jean El-Cheikh, Gesine Bug, Aleksandra Holowiecka, Arnon Nagler, Fabio Ciceri, Florent Malard
Improved post-transplant outcomes in recent years for AML patients with FLT3-ITD and wild-type NPM1: a report from the EBMT acute leukemia working party. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)